Atea Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $574k | 107k | 5.39 |
| 2025-12-31 | $348k | 97k | 3.58 |
| 2025-09-30 | $283k | 98k | 2.90 |
| 2025-06-30 | $288k | 80k | 3.60 |
| 2025-03-31 | $239k | 80k | 2.99 |
| 2024-12-31 | $248k | 74k | 3.36 |
| 2024-09-30 | $235k | 70k | 3.36 |
| 2024-06-30 | $221k | 67k | 3.32 |
| 2024-03-31 | $272k | 67k | 4.05 |
| 2023-12-31 | $169k | 55k | 3.06 |
| 2023-09-30 | $127k | 42k | 3.01 |
| 2023-06-30 | $155k | 41k | 3.76 |
| 2023-03-31 | $134k | 40k | 3.37 |
| 2022-12-31 | $139k | 29k | 4.82 |
| 2022-03-31 | $3.2M | 446k | 7.22 |
| 2021-12-31 | $3.7M | 413k | 8.94 |
| 2021-09-30 | $52M | 1.5M | 35.06 |
| 2021-06-30 | $36M | 1.7M | 21.48 |
| 2021-03-31 | $154M | 2.6M | 60.05 |
| 2020-12-31 | $102M | 2.5M | 40.61 |